Page last updated: 2024-11-02

pirenzepine and Brain Edema

pirenzepine has been researched along with Brain Edema in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Brain Edema: Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6)

Research Excerpts

ExcerptRelevanceReference
"A total of 120 patients suffering from brain tumors was included in this study."2.66[Report of experience with stomach-protective therapy in high-dosage corticosteroid treatment of patients with brain tumors]. ( Hirschl, M, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirschl, M1

Trials

1 trial available for pirenzepine and Brain Edema

ArticleYear
[Report of experience with stomach-protective therapy in high-dosage corticosteroid treatment of patients with brain tumors].
    Wiener medizinische Wochenschrift (1946), 1988, Mar-15, Volume: 138, Issue:5

    Topics: Administration, Oral; Anti-Ulcer Agents; Brain Edema; Brain Neoplasms; Dexamethasone; Dose-Response

1988